Organization Overview
Historical Acquisition Tree
Alternative names
Key: MDS Pharma (45) Acquired (2)
acetylsalicylic acid (aspirin) (1 trial)
amlodipine (norvasc) (4 trials)
anthrax immune globulin (Anthrasil) (1 trial)
azithromycin (zithromax) (2 trials)
benazepril (lotensin) (2 trials)
botulinum antitoxin heptavalent (a b c d e f g) - (equine) (1 trial)
cefuroxime (zinacef) (4 trials)
clomipramine (anafranil) (2 trials)
conjugated equine estrogens (Premarin) (1 trial)
deoxycholic acid (kybella) (1 trial)
desmopressin (ddavp) (1 trial)
esomeprazole (nexium) (1 trial)
fluconazole (diflucan) (2 trials)
fluvastatin (lescol) (1 trial)
imipramine (tofranil) (1 trial)
ketoconazole (nizoral) (1 trial)
levetiracetam (keppra) (5 trials)
medroxyprogesterone (provera) (1 trial)
mifepristone (mifeprex) (1 trial)
Anthrax (Phase 1)
Arteriosclerosis (Phase 4)
Asthma (Phase 3)
Bipolar Disorder (Phase 4)
Breast Neoplasms (Phase 2)
Colonic Polyps (Phase 3)
Coronary Artery Disease (Phase 4)
Depression (Phase 4)
Depressive Disorder (Phase 4)
Erectile Dysfunction (Phase 1)
Hearing Loss (Phase 1)
Heart Failure (Phase 2)
Hypercholesterolemia (Phase 4)
Influenza, Human (Phase 2)
Malnutrition (Phase 1)
Myocardial Ischemia (Phase 4)
Overweight (Phase 2)
Pain, Postoperative (Phase 3)
Rabies (Phase 2)
Seizures (Phase 1)
Sexual Dysfunctions, Psychological (Phase 1)
Tuberculosis (Phase 1)